VanEck Biotech ETF
BBH
BBH
82 hedge funds and large institutions have $179M invested in VanEck Biotech ETF in 2017 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 22 increasing their positions, 24 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
8.02% less ownership
Funds ownership: 34.65% → 26.63% (-8%)
28% less capital invested
Capital invested by funds: $249M → $179M (-$69.4M)
Holders
82
Holding in Top 10
–
Calls
$1.48M
Puts
$911K
Top Buyers
| 1 | +$4.9M | |
| 2 | +$4.28M | |
| 3 | +$2.61M | |
| 4 |
OLA
Oliver Luxxe Assets
Gladstone,
New Jersey
|
+$1.57M |
| 5 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$1.38M |
Top Sellers
| 1 | -$50.4M | |
| 2 | -$13.4M | |
| 3 | -$2.42M | |
| 4 |
AL
Aspiriant LLC
Los Angeles,
California
|
-$2.13M |
| 5 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$1.8M |